MX2009010173A - Derivados de aminometil aza-adamantano y uso de los mismos como moduladores selectivos del receptor de acetilcolina nicotinico alfa-7 neuronal (nnrs). - Google Patents

Derivados de aminometil aza-adamantano y uso de los mismos como moduladores selectivos del receptor de acetilcolina nicotinico alfa-7 neuronal (nnrs).

Info

Publication number
MX2009010173A
MX2009010173A MX2009010173A MX2009010173A MX2009010173A MX 2009010173 A MX2009010173 A MX 2009010173A MX 2009010173 A MX2009010173 A MX 2009010173A MX 2009010173 A MX2009010173 A MX 2009010173A MX 2009010173 A MX2009010173 A MX 2009010173A
Authority
MX
Mexico
Prior art keywords
acetylcholine receptor
nicotinic acetylcholine
amimomethyl
nnrs
alpha7
Prior art date
Application number
MX2009010173A
Other languages
English (en)
Spanish (es)
Inventor
William H Bunnelle
Lei Shi
Marc J C Scanio
Original Assignee
Abbott Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Lab filed Critical Abbott Lab
Publication of MX2009010173A publication Critical patent/MX2009010173A/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/18Bridged systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16Anti-Parkinson drugs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Psychology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
MX2009010173A 2007-03-23 2008-03-20 Derivados de aminometil aza-adamantano y uso de los mismos como moduladores selectivos del receptor de acetilcolina nicotinico alfa-7 neuronal (nnrs). MX2009010173A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US89675507P 2007-03-23 2007-03-23
PCT/US2008/057652 WO2008118747A1 (en) 2007-03-23 2008-03-20 Amimomethyl azaadamantane derivatives and use thereof as selective modulators of the alpha7- neuronal nicotinic acetylcholine receptor (nnrs)

Publications (1)

Publication Number Publication Date
MX2009010173A true MX2009010173A (es) 2009-10-12

Family

ID=39620402

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2009010173A MX2009010173A (es) 2007-03-23 2008-03-20 Derivados de aminometil aza-adamantano y uso de los mismos como moduladores selectivos del receptor de acetilcolina nicotinico alfa-7 neuronal (nnrs).

Country Status (7)

Country Link
US (1) US8168791B2 (enExample)
EP (2) EP2129673B1 (enExample)
JP (1) JP5394940B2 (enExample)
CN (1) CN101675049A (enExample)
CA (1) CA2679885A1 (enExample)
MX (1) MX2009010173A (enExample)
WO (1) WO2008118747A1 (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI1015043A2 (pt) * 2009-06-19 2019-07-09 Abbott Lab derivados de diazahomoadamantano e métodos de uso dos mesmos
US10183938B2 (en) 2014-12-16 2019-01-22 Axovant Sciences Gmbh Geminal substituted quinuclidine amide compounds as agonists of α-7 nicotonic acetylcholine receptors
JP2018516973A (ja) 2015-06-10 2018-06-28 フォーラム・ファーマシューティカルズ・インコーポレイテッドForum Pharmaceuticals Inc. α7−ニコチン性アセチルコリン受容体のアゴニストとしてのアミノベンゾイソオキサゾール化合物
EP3334740A4 (en) 2015-08-12 2019-02-06 Axovant Sciences GmbH GEMINAL SUBSTITUTED AMINOBENZISOXAZOLE COMPOUNDS AS AGONISTS OF ALPHA 7-NICOTINIC ACETYLCHOLINE RECEPTORS

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8523211D0 (en) 1985-09-19 1985-10-23 Beecham Group Plc Compounds
US5260303A (en) 1991-03-07 1993-11-09 G. D. Searle & Co. Imidazopyridines as serotonergic 5-HT3 antagonists
US5280028A (en) 1992-06-24 1994-01-18 G. D. Searle & Co. Benzimidazole compounds
US5434151A (en) 1992-08-24 1995-07-18 Cytomed, Inc. Compounds and methods for the treatment of disorders mediated by platelet activating factor or products of 5-lipoxygenase
US5840903A (en) 1992-07-27 1998-11-24 G. D. Searle & Co. 4-aminomethyl-1-azaadamantane derived benzamides
JP3235913B2 (ja) * 1993-07-30 2001-12-04 エーザイ株式会社 アミノ安息香酸誘導体
US5399562A (en) 1994-02-04 1995-03-21 G. D. Searle & Co. Indolones useful as serotonergic agents
US7897766B2 (en) 2005-09-23 2011-03-01 Abbott Laboratories Amino-aza-adamantane derivatives and methods of use

Also Published As

Publication number Publication date
EP2129673B1 (en) 2013-11-06
CA2679885A1 (en) 2008-10-02
CN101675049A (zh) 2010-03-17
WO2008118747A1 (en) 2008-10-02
US8168791B2 (en) 2012-05-01
JP5394940B2 (ja) 2014-01-22
EP2505588B1 (en) 2013-11-13
JP2010522204A (ja) 2010-07-01
EP2505588A1 (en) 2012-10-03
EP2129673A1 (en) 2009-12-09
US20080262023A1 (en) 2008-10-23

Similar Documents

Publication Publication Date Title
MY189750A (en) Selective sphingosine 1 phosphate receptor modulators and methods of chiral synthesis
MX2010005648A (es) Derivados de alcano azabiciclico sustituidos con biarilo como moduladores de la actividad del receptor nicotinico de acetilcolina.
WO2009059994A3 (en) Methods and compositions for measuring wnt activation and for treating wnt-related cancers
PH12012500940B1 (en) Selective heterocyclic sphingosine 1 phosphate receptor modulators
WO2008152099A3 (en) Aryl/hetarylamides as modulators of the ep2 receptor
WO2009016253A3 (en) Cyanomethyl substituted n-acyl tryptamines
PH12012500938A1 (en) Sphingosine 1 phosphate receptor modulators and methods of chiral synthesis
WO2011069063A3 (en) Multicyclic compounds and methods of use thereof
EA200900831A1 (ru) Модуляторы никотиновых ацетилхолиновых рецепторов
JO2701B1 (en) Vehicles
WO2007109279A3 (en) Tetrahydropyridothienopyrimidine compounds and methods of use thereof
WO2007138282A3 (en) Bi-aryl or aryl-heteroaryl substituted indoles
MX2012004548A (es) Nuevas composiciones para prevenir y/o tratar transtornos degenerativos del sistema nervioso central.
GB0510143D0 (en) Novel compounds A1
WO2006123249A3 (en) Novel oxadiazole derivatives and their use as positive allosteric modulators of metabotropic glutamate receptors
WO2008045371A3 (en) N-substituted-azacyclylamines as histamine-3 antagonists
WO2012158550A3 (en) Selective heterocyclic sphingosine 1 phosphate receptor modulators
WO2007053765A3 (en) Substituted cycloalkylpyrrolones as allosteric modulators of glucokinase
WO2009051718A3 (en) Calcium receptor modulating agents
WO2008147812A3 (en) 4' substituted compounds having 5-ht6 receptor affinity
WO2009037542A3 (en) Spirocyclic compounds as stearoyl coa desaturase inhibitors
WO2006123255A3 (en) Substituted oxadiazole derivatives as positive allosteric modulators of metabotropic glutamate receptors
MX2009010173A (es) Derivados de aminometil aza-adamantano y uso de los mismos como moduladores selectivos del receptor de acetilcolina nicotinico alfa-7 neuronal (nnrs).
WO2010057088A3 (en) Pyrrolidinyl modulators of nicotinic acetylcholine receptors
WO2010147969A3 (en) Gamma secretase modulators

Legal Events

Date Code Title Description
FG Grant or registration
GB Transfer or rights